Dr. Takuji Shirasawa is an anti-aging practitioner at Ochanomizu Longevity Clinic and Director and Researcher at Shirasawa Anti-Aging Medical Research Institute.

Dr. Takuji Shirasawa graduated from the Chiba University School of Medicine in 1982, he joined the respiratory medicine department. In 1990, he completed his doctoral program at the same university’s Graduate School of Medicine, obtaining a doctorate in medicine. He has worked as a researcher in the pathology department and the neurophysiology section at the Tokyo Metropolitan Institute of Gerontology, and as a molecular aging research group leader and aging genome biomarker research team leader. From 2007 to 2015, he was a professor at the Aging Control Medicine Course in the Graduate School of Medicine at Juntendo University, and his lectures abroad were well-received. His specialties are molecular genetics of lifespan control genes, molecular biology of Alzheimer’s disease, and genetic research on athletes. He is the president of the International Preventive Medicine Association, the president of the Japan Anti-Aging Food Association, and the CEO of Anti-Aging Science. In 2017, he became the director of the Ochanomizu Health and Longevity Clinic, and in 2018, he became the director of Residence of Hope in Ashikaga. In 2021, he was appointed as the president of the International Preventive Medicine Association, and in 2022, he became the chairman of the Cognitive Disorders Subcommittee of the International Personalized Medicine Association. He has written over 300 books in the last 20 years, including “101 Ways to Avoid Becoming Senile by Age 100,” “Overcoming Aging,” He has a weekly column in the Thursday evening edition of the Mainichi Shimbun newspaper called “Dr. Shirahama’s Road to Age 100,” which has been running for 8 years and reached its 400th issue in the September 24, 2020 issue.